| COMPANY | DRUG | Research | Preclin | Phase 1 | Phase 2 | Phase 3 | NDA |
| Vertex |
Telaprevir (VX-950) Protease Inhibitor |
 |
|||||
| Vertex |
VX-500 protease inhibitor | |
|||||
| Vertex |
VX-813 2nd gen protease inhibitor |
|
|||||
| Schering |
Boceprevir (SCH503034) Protease inhibitor |
|
|||||
| Intercell Novartis |
IC41 Therapeutic Vacccine | |
|||||
| Chiron / CSL |
Therapeutic Vaccine CSL123 |
|
|||||
| Roche |
R1626 Polymerase inhibitor | |
|||||
| Intermune / Roche |
Protease inhibitor ITMN-191 R7227 |
|
|||||
| Roche / Pharmasset |
R7128 nucleoside polymerase inhibitor |
|
|||||
| Roche / Medivir |
HCV polymerase inhibitor |
|
|||||
| Medivir / Tibotec |
TMC435350 Protease inhibitor | |
|||||
| Pfizer |
PF-868554 Non-Nuc Polymerase inhibitor |
|
|||||
| Benitec / Tacere Bio / Pfizer |
RNA interference TT033 |
|
|||||
| ViroChem Pharma |
VCH-759 Non nuc Polymerase inhib |
|
|||||
| ViroChem Pharma |
Polymerase inhib |
|
|||||
| ViroChem Pharma |
Polymerase inhib |
|
|||||
| Globeimmune |
GI 5005 Therapeutic Vaccine |
|
|||||
| Merck |
MK-7009 protease inhibitor |
|
|||||
| Sirna Therapeutics (aquired by Merck) |
SIRNA-034 RNAi RNA interference |
|
|||||
| Isis / Merck |
MK-0608 nucleoside polymerase inhib. |
|
|||||
| Abbott |
A-837093 Non-nuc polymerase inhib |
|
|||||
| Gilead |
GS 9190 non-nuc polymerase inhibitor |
|
|||||
| Gilead / Achillion |
ACH-1095 Protease inhibitor |
|
|||||
| Gilead |
Protease polymerase inhib |
|
|||||
| GlaxoSmithKline |
GSK625433 NonNu Polymerase Inhibitor |
|
|||||
| Aethlon Medical |
Hemopurifier |
|
|||||
| Transgene |
TG4040 (MVA-HCV) Therapeutic Vaccine |
|
|||||
| Tripep / Inovio |
Therapeutic Vaccine Chronvac-C |
|
|||||
| Arrow Therapeutics (aquired by AstraZeneca) |
A-831 NS5A inhibitor | |
|||||
| Arrow Therapeutics |
A-689 NS5A Inhibitor |
|
|||||
| GENimmune (subsidiary of Innogenetics) |
GNI-103 – Therapeutic vaccine |
|
|||||
| GENimmune |
GNI-104 - monoclonal antibodie E1 protein |
|
|||||
| Idenix |
IDX102 | |
|||||
| Idenix |
IDX184 Nucleoside Polymerase Inhibitor |
|
|||||
| Idenix |
Protease Inhibitor |
|
|||||
| Biocryst |
Polymerase inhibitor |
|
|||||
| Genelabs GL59728 & GL60667 |
Non-nucleoside & nucleoside polymerase inhib. |
|
|||||
| Genelabs |
NS5a NS4b & Replicase inhibitors | |
|||||
| ViRex Medical |
Hepavaxx C Therapeutic Vaccine |
|
|||||
| GenPhar |
Vaccine |
|
|||||
| Genmab |
HuMax-HepC antibody |
|
|||||
| Abbott / Enanta |
Protease inhib | |
|||||
| Enanta |
Polymerase Inhibitor |
|
|||||
| Enanta |
Cyclophilin binder |
|
|||||
| Anadys |
ANA598 Polymerase inhib |
IND 2nd Qtr. '08 |
|||||
| Dynavax |
Immunostimulatory sequences Type C TLR9 agonist |
|
|||||
| Protiva Biotherapeutics |
siRNA |
|
|||||
| Phenomix |
PHX1766 protease inhibitor | |
|||||
| Phenomix |
protease inhibitor |
|
|||||
| Phenomix |
Polymerase Inhibitor |
|
|||||
| Samaritan Pharmaceuticals |
SP-30 entry inhibitor |
|
|||||
| Presidio (aquired from XTL ) |
NS5A inhibitors |
|
|||||
| Migenix |
N-nucleoside Poly inhib |
|
|||||
| Merck / Metabasis |
Polymerase inhib small molecule |
|
|||||
| PTC / Schering |
IRES inhib |
|
|||||
| Vertex |
Helicase inhibitor |
|
|||||
| Medivir / Roche |
Polymerase inhibor | |
|||||
| Cetek |
small molecule |
|
|||||
| Ithrex (Immusol) / Novartis |
ITX2155 | |
|||||
| Argos Therapeutics |
Therapeutic Vaccine | |
|||||
| Tibotec |
Polymerase inhib. | |
|||||
| Regulus Therapeutics (Alnylam / Isis) |
microRNA antagonism of miR-122 host gene |
|
|||||
| CombiMatrix |
RNAi | |
|||||
| Progenics |
entry inhibitor |
|
|||||
| Arrow Therapeutics |
Polymerase inhibitor |
|
|||||
| Boehringer Ingelheim / Biota |
Nucleoside analogues |
|
|||||
| BioLeap |
???? |
|
|||||
| Inhibitex |
Polymerase inhibitor |
|
|||||
| Alios BioPharma |
Small Molecule Antivirals |
|
|||||
| Presidio / Numerate |
???? |
|
|||||
| Biotron |
targeting HCV-p7 |
|
|||||
| NanoViricides |
HepaCide-I |
|
|||||
| Hanall |
Antihepatitis agents |
|
|||||
| VGX Pharma |
VGX-410C IRES inhibitor |  Discontinued |
|||||
| COMPANY | DRUG | Research | Preclin | Phase 1 | Phase 2 | Phase 3 | NDA |
| Human Genome Sciences |
Albuferon (interferon / albuminfusion) |
|
|||||
| SciClone Pharma / Sigmatau |
Zadaxin - thymalfasin |
|
|||||
| Migenix |
MX3235 Celgosivir alpha-glucosidase I inhibitor |
|
|||||
| Intarcia |
Omega Interferon | |
|||||
| NABI |
Polyclonal antibody Civacir |
|
|||||
| Bioenvision |
Suvus | |
|||||
| Transition Therapeutics |
IET Interferon Enhancing Therapy |
|
|||||
| Romark Laboratories |
Alinia | |
|||||
| Biolex / OctoPlus |
Locteron controlled release interferon |
|
|||||
| Kemin Pharma |
KPE02003002 |
|
|||||
| VioQuest Pharmaceuticals |
Lenocta (sodium stibogluconate SSG) |
|
|||||
| Conatus |
CTS-1027 MMP inhibitor |
|
|||||
| Jenkin |
JKB-122 antiinflammatory |
|
|||||
| Oklahoma University Health Sciences Center |
Fluvastatin |
|
|||||
| Antipodean |
Mito-Q antiinflammatory |
 |
|||||
| Phynova |
PYN17 antiviral anti-inflammatory anti-fibrotic |
|
|||||
| Phynova |
PYN18 anti viral plant extract |
|
|||||
| Biotron |
BIT225 | |
|||||
| Peregrine Pharm |
Bavituximab | |
|||||
| Enzo Biochem |
Immune Regulator ECH18 |
|
|||||
| Immunomedics |
IMMU 105 | |
|||||
| Amarillo Bioscience / CytoPharm |
Low Dose Oral Interferon | |
|||||
| Novelos |
NOV-205 immunomodulating and antiinflammatory |
|
|||||
| Idera |
IMO-2125 TLR9 Agonist |
|
|||||
| Debiopharm |
Debio 025 Cyclophilin Inhibitor |
|
|||||
| Medarex / Ono |
MDX-1106 (ONO-4538) anti-PD1 |
IND for HCV aproved |
|||||
| Cubist |
CB-183872 Protein therapeutic - Formerly IB657 (Illumigen Biosciences) |
|
|||||
| Kemin Pharma |
KPE00001133 |
|
|||||
| REPLICor |
REP 9C broad-spectrum entry inhibitor |
|
|||||
| Nautilus |
Oral Belerofon |
|
|||||
| Anadys |
AN 025-1 |
|
|||||
| Genodyssee |
GEA007.1 IFN alpha variant |
|
|||||